Quotes 5-day view Delayed Nasdaq
03/01/2021
03/02/2021
03/03/2021
03/04/2021
03/05/2021
Date
446.5(c)
441.01(c)
416.41(c)
399.61(c)
398.85(c)
Last
865 465
753 114
1 130 830
1 268 038
1 177 556
Volume
+1.61% -1.23% -5.58% -4.03% -0.19% Change
Sales 2021
3 924 M - -
Net income 2021
749 M - -
Net Debt 2021
436 M - -
P/E ratio 2021
80,2x
Yield 2021
-
Sales 2022
4 567 M - -
Net income 2022
913 M - -
Net cash position 2022
163 M - -
P/E ratio 2022
66,0x
Yield 2022
-
Capitalization
58 192 M 58 192 M -
EV / Sales 2021
14,9x
EV / Sales 2022
12,7x
Nbr of Employees
7 825
Free-Float
74,7%
Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows:
- product sales (84.4%): tools and...
Notations Surperformance© of Illumina, Inc.
Trading Rating : Investor Rating :
All news about ILLUMINA, INC.
03/05 ILLUMINA : and R-Pharm Secure Registration for Two Complete IVD Sequencing Plat..BU
03/04 ILLUMINA, INC. : Other Events (form 8-K)AQ
03/03 ILLUMINA : Barclays Starts Illumina at Underweight With $325 Price TargetMT
02/19 ILLUMINA : Continued Level of Significant Insider Selling at Illumina (ILMN)MT
02/19 ILLUMINA : and the University Hospital of Tübingen Evaluate Potential of Whole ..BU
02/18 INSIDER TRENDS : Insider Disposition Eases Back 90-Day Buy Trend at IlluminaMT
02/18 INSIDER TRENDS : Illumina Insider Gets Share Award, Exercises Derivative Securit..MT
02/18 INSIDER TRENDS : Illumina Insider Awarded Stock, Exercises Derivative Security, ..MT
02/18 INSIDER TRENDS : Insider at Illumina Gets Share Award, Exercises Derivative Secu..MT
02/18 INSIDER TRENDS : Illumina Insider Awarded Stock, Converts/Exercises Derivative S..MT
02/18 INSIDER TRENDS : Insider at Illumina Awarded Stock, Converts/Exercises Derivativ..MT
02/18 INSIDER TRENDS : Insider at Illumina Awarded Shares, Converts/Exercises Derivati..MT
02/18 INSIDER TRENDS : Insider at Illumina Gets Stock Award, Converts/Exercises Deriva..MT
02/18 INSIDER TRENDS : Insider at Illumina Receives Share Award, Converts/Exercises De..MT
02/16 ILLUMINA : BTIG Adjusts Price Target on Illumina to $570 From $410, Maintains B..MT
News in other languages on ILLUMINA, INC.
Analyst Recommendations on ILLUMINA, INC.
Illumina to buy Jeff Bezos-backed cancer testing firm Grail in £6.23 billion deal
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends ILLUMINA, INC.
Short Term Mid-Term Long Term Trends Bearish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
HOLD
Number of Analysts
19
Average target price
407,39 $
Last Close Price
398,85 $
Spread / Highest target
42,9%
Spread / Average Target
2,14%
Spread / Lowest Target
-31,1%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
